Small Molecule Outsourcing STREAM

31. Small Molecule APIs: From Pre-RSM To Final API 8/31/2023

    As a leader in small molecule manufacturing, Ajinomoto Bio-Pharma Services has over 40 years of experience providing high quality APIs and intermediates for pharmaceutical companies throughout the world.

32. Expanding The OSD Toolbox 10/3/2024

    This session is designed to provide practical solutions for enhancing bioavailability and scalability in pharmaceutical formulations.

33. Cambrex Scientist Spotlight: Ross McLellan 1/29/2025

    Ross McLellan, Team Lead for Solid Form Screening in Edinburgh, UK, leads a team dedicated to complex solid form screening and materials characterization for Cambrex’s global client base.

34. Analytical Reference Materials For The Pharma Industry 11/20/2023

    Reference materials are critical for manufacturers to ensure safe and efficient drug material production. Discover a partner that provides high-quality analytical tools to meet your process needs.

35. Integration From Formulation Development To Manufacturing, Packaging 2/27/2025

    Adare Pharma Solutions' Pessano, Italy facility offers 220,000 sq. ft. of end-to-end services, including R&D, formulation development, clinical and commercial manufacturing, packaging, and advanced analytical capabilities.

36. Your Journey To GMP With Emphasis On Linker Payload Development 10/22/2025

    Develop lower-risk conjugation strategies by incorporating the critical insights we highlight in our review of semi-synthetic versus synthetic linker–payloads and their respective advantages and limitations.

37. Improve The Bioavailability Of Poorly Soluble Drugs 3/19/2024

    KinetiSol is a fusion-based, solvent-free process that utilizes frictional and shear energies — in a fraction of the time of other amorphous solid dispersion technologies.

38. The Key To HPAPI Manufacturing Success 3/1/2024

    Watch to explore a training center dedicated to the development and manufacturing of HPAPIs that is setting a new industry standard for safety and expertise.

39. ADHD Awareness: How This Novel Technology Can Guide The Way 4/9/2023

    Explore Nanoform's innovative nanoparticle technology and the value it can bring to molecules in development or products on the market for neurological disorders such as ADHD.

40. Overcoming Obstacles On The Journey To Commercialization 5/28/2024

    Explore case studies in the development and manufacturing of APIs and HPAPIs as well as innovative solutions designed to address and overcome challenges in bringing new medicines to patients.